Page 8 - Adalimumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adalimumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adalimumab Today - Breaking & Trending Today

Navigating Challenges Associated with Biosimilars Across Various Disease States

Clinical and social challenges associated with biosimilars are discussed by key opinion leaders. ....

Women Health , Population Health , Digital Health , Commercial Payer ,

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

Like several immunosuppressive biologics, the JAK inhibitor upadacitinib is also approved for the treatment of Crohn's disease. Commissioned by the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated in an early benefit assessment whether the drug offers an added benefit versus the appropriate comparator therapy to patients with moderate to severe active Crohn's disease who have had an inadequate response, lost response or are intolerant to conventional therapy or a biologic agent. ....

Megan Craig , Daniela Preukschat , Iqwig Drug Assessment Department , Institute For Quality , Efficiency In Health Care Iqwi , Federal Joint Committee , Health Care , Drug Assessment Department , Drug Assessment , Medicinal Products , Health Care , Inflammatory Bowel Disease , Jak Inhibitor ,

Utilizing Recently Approved Biosimilars in Clinical Practice

Experts explore current and future use of biosimilars in dermatology, gastroenterology, and rheumatology. ....

Bincy Abraham , Ryan Haumschild , Aliceb Gottlieb , Jamiet Brogan , Department Of Dermatology , Academic Division Of Gastroenterology , Division Of Immunology , Stanford University School Of Medicine , Winship Cancer Institute , Icahn School Of Medicine At Mount Sinai , Emory Healthcare , Icahn School , Mount Sinai , Academic Division , Houston Methodist Hospital , Northwestern Medicine , Vibeke Strand , Stanford University School , Voltaire Trial , Inflammatory Bowel Disease , Crohns Disease , Ulcerative Colitis , Originator Biologic , Colorectal Surgeon ,

Transitioning to Biosimilars: Considerations for Providers and Payers

Panelists explore opportunities for biosimilars to manage inflammatory conditions. ....

Jamiet Brogan , Aliceb Gottlieb , Ryan Haumschild , Bincy Abraham , Vibeke Strand , Cost Saving Opportunities , Voltaire Trial , Crohns Disease , Biosimilar Transition , Preferred Brand , Non Preferred Brand ,

Patient Satisfaction, Drug Survival of Switches to Adalimumab Biosimilars

Posters presented at the EADV Congress highlighted that despite similar efficacy, patient perception can affect satisfaction with the switch from the reference adalimumab to a biosimilar. ....

European Academy Of Dermatology , European Academy , Syda Productions , Psoriasis Area , Severity Index , Patient Satisfaction ,